Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Glenn Miles currently holds 150,000 shares of CANCER GENETICS, INC (CGIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Glenn Miles has been a net buyer of CGIX stock. They have purchased $34.5K and sold $0 worth of shares.
Michael Glenn Miles's most recent insider trade was on Jan 31, 2019, when they purchased 150,000 shares at $0.23 per share.
Michael Glenn Miles serves as Executive at CANCER GENETICS, INC (CGIX). They have executed 1 insider transactions totaling $34.5K over their tenure at the company.
Michael Glenn Miles holds the position of Executive at CANCER GENETICS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Michael Glenn Miles has shown a buying trading pattern, with $34.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael Glenn Miles was on Jan 31, 2019, when they purchased $34.5K worth of CGIX shares. This transaction involved 150,000 shares at $0.23 per share.
Michael Glenn Miles currently owns 150,000 shares of CANCER GENETICS, INC (CGIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Glenn Miles's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Glenn Miles has 1 Form 4 filings on record as an insider at CANCER GENETICS, INC.
Set alerts for Michael Glenn Miles and 40,000+ other insiders.